Danaher Corporation | Large-cap | Healthcare
$202.50
0.70%
| Danaher Stock Comparison:
Danaher vs Thermo FisherDanaher vs Idexx LaboratoriesDanaher vs Agilent TechnologiesDanaher vs Iqvia HoldingsDanaher vs Mettler-ToledoDanaher vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 23.9B
Gross Profit 14.2B 59.50%
Operating Income 4.9B 20.37%
Net Income 3.9B 16.33%
EPS (Diluted) $5.29

Balance Sheet Metrics

Total Assets 77.5B
Total Liabilities 28.0B
Shareholders Equity 49.6B
Debt to Equity 0.56

Cash Flow Metrics

Operating Cash Flow 6.6B
Free Cash Flow 5.3B

Revenue & Profitability Trend

Danaher Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 23.9B 23.9B 26.6B 24.8B 22.3B
Cost of Goods Sold 9.7B 9.9B 10.5B 9.6B 9.8B
Gross Profit 14.2B 14.0B 16.2B 15.2B 12.5B
Operating Expenses 9.3B 8.8B 8.7B 8.9B 8.2B
Operating Income 4.9B 5.3B 7.5B 6.4B 4.2B
Pre-tax Income 4.6B 5.0B 7.1B 6.5B 4.5B
Income Tax 747.0M 823.0M 818.0M 1.1B 849.0M
Net Income 3.9B 4.8B 7.2B 6.4B 3.6B
EPS (Diluted) $5.29 $6.38 $9.66 $8.61 $4.89

Income Statement Trend

Danaher Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 9.5B 13.9B 15.9B 11.6B 13.8B
Non-Current Assets 68.0B 70.6B 68.5B 71.5B 62.4B
Total Assets 77.5B 84.5B 84.4B 83.2B 76.2B
Liabilities
Current Liabilities 6.8B 8.3B 8.4B 8.1B 7.4B
Non-Current Liabilities 21.2B 22.7B 25.9B 29.9B 29.0B
Total Liabilities 28.0B 31.0B 34.3B 38.0B 36.4B
Equity
Total Shareholders Equity 49.6B 53.5B 50.1B 45.2B 39.8B

Balance Sheet Composition

Danaher Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 3.9B 4.2B 6.3B 5.4B 3.6B
Operating Cash Flow 6.6B 5.9B 7.3B 7.7B 6.4B
Investing Activities
Capital Expenditures -1.4B -1.4B -1.1B -1.2B -789.0M
Investing Cash Flow -2.0B -7.0B -2.1B -12.9B -21.2B
Financing Activities
Dividends Paid -768.0M -1.2B -818.0M -742.0M -615.0M
Financing Cash Flow -8.4B -273.0M -2.6B 1.3B 1.0B
Free Cash Flow 5.3B 5.8B 7.4B 7.1B 5.4B

Cash Flow Trend

Danaher Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 37.98
Forward P/E 23.43
Price to Book 2.76
Price to Sales 5.90
PEG Ratio 23.43

Profitability Ratios

Profit Margin 15.81%
Operating Margin 22.49%
Return on Equity 7.22%
Return on Assets 3.93%

Financial Health

Current Ratio 1.43
Debt to Equity 34.56
Beta 0.80

Per Share Data

EPS (TTM) $5.17
Book Value per Share $71.06
Revenue per Share $32.86

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
dhr 140.5B 37.98 2.76 7.22% 15.81% 34.56
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Idexx Laboratories 42.1B 48.33 29.21 59.33% 22.76% 73.16
Agilent Technologies 33.0B 28.60 5.37 18.88% 17.59% 60.04
Iqvia Holdings 27.4B 21.64 4.61 21.64% 8.61% 242.91
Mettler-Toledo 24.0B 28.82 -135.91 -680.23% 22.17% -11.40

Financial data is updated regularly. All figures are in the company's reporting currency.